Licensed drug could reduce SARS-CoV-2 infection

Quicklink Submitted By Scott Baker 6 comments

Managing Editor
Scott Baker

Become a Fan
(78 fans)

Vaccines will not be available to everyone on Earth for months, or longer. In the meantime we need post-infection treatments too.
(Image by focusonmore.com) Details DMCA

A licensed drug normally used to treat abnormal levels of fatty substances in the blood could reduce infection caused by the SARS-CoV-2 virus by up to 70 percent, reveals a study in the laboratory by an international collaboration of researchers.

Read the rest of the story HERE:

At medicalxpress.com

1
Rate It | View Ratings

Scott Baker Social Media Pages:

Scott Baker is a Managing Editor & The Economics Editor at Opednews, and a former blogger for Huffington Post, Daily Kos, and Global Economic Intersection.

His anthology of updated Opednews articles "America is Not Broke" was published by Tayen Lane Publishing (March, 2015) and may be found here:
http://www.americaisnotbroke.net/

Scott is a former and current President of Common Ground-NY (http://commongroundnyc.org/), a Geoist/Georgist activist group. He has written dozens of (more...)

Related Topic(s): Corona Virus Coronavirus Covid-19; Covid-19; Drugs, Add Tags

Go To Commenting

The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.

Contact Author

Contact Editor

View Authors' Articles

OpEdNews ~~depends upon~~ can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.

To View Comments or Join the Conversation: